- KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer.Molecular oncology, 2020.
- A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal CancerCai, Guoxiang*; Cai, Mingyan; Feng, Zhiqiang; Liu, R. U., I*; Liang, L., I*; Zhou, Pinghong*Gastroenterology, 2021, 161(6): 2053-+.被引 29
- Non-invasive detection of pancreatic cancer by measuring DNA methylation of Basonuclin 1 and Septin 9 in plasmaLi, Xiao Bin; Ma, Jun; Liu, Zi Wen; He, Wen Fei; Li, Zong Ze; Cui, Ming; Hao, Huang; Zhou, Guang Peng; You, Lei; Wang, James; Han, Xiao Liang; Zhao, Yu Pei*Chinese Medical Journal, 2019, 132(12): 1504-1506.
会议论文
Early detection of lung cancer using a panel of circulating cell-free DNA methylation biomarkers
23阅读
